Reviewing the Potential of Psychedelics for the Treatment of PTSD.
Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T., & Vermetten, E. | International Journal of Neuropsychopharmacology | 14 March 2020
Self-Experiments with Psychoactive Substances: A Historical Perspective
Passie, T., & Brandt, S. D. | Handbook of Experimental Pharmacology | 27 November 2018
The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)
Passie, T. | Drug Science, Policy and Law | 11 April 2018
MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s)
Passie, T., & Benzenhöfer, U. | Drug testing and analysis | 29 August 2017
The History of MDMA as an Underground Drug in the United States, 1960-1979
Passie, T., & Benzenhöfer, U. | Journal of psychoactive drugs | 03 March 2016
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Gasser, P., Kirchner, K., & Passie, T. | Journal of Psychopharmacology | 11 November 2014
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series
Karst, M., Halpern, J. H., Bernateck, M., & Passie, T. | Cephalalgia | 26 Mar 2010
Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion
Passie, T., Hartmann, U., Schneider, U., Emrich, H. M., & Krüger, T. H. | Medical hypotheses | 09 Nov 2004